Parvovirus infection-induced cell death and cell cycle arrest

Future Virology

Volumn 5, Issue 6, 2010, Pages 731-743

  Chen, Aaron Yun ^a   Qiu, Jianming ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

cell cycle arrest; cell death; DNA damage response; Parvovirus

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE; NONSTRUCTURAL PROTEIN 1; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ALEUTIAN MINK DISEASE VIRUS; APOPTOSIS; BOCAVIRUS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CYTOPATHOGENIC EFFECT; HUMAN PARVOVIRUS B19; MOLECULAR MECHANICS; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

BOVINE PARVOVIRUS; H-1 PARVOVIRUS; MINUTE VIRUS OF MICE; PARVOVIRUS;

EID: 78650062665     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.56     Document Type: Review

References (148)

1. Knipe DM, Howley PM, Griffn DE et al.: Parvoviruses. In: Field's Virology. (5th Edition). Lippincott Williams & Wilkins, Philadelphia, PA, USA (2007).
2. Parvoviruses (1st Edition). Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR (Eds). Hodder Arnold, London, UK (2006).
3. Berns KI, Giraud C: Biology of adeno-associated virus. Curr. Top. Microbiol Immunol. 218, 1-23 (1996).
4. Fryer JF, Kapoor A, Minor PD, Delwart E, Baylis SA: Novel parvovirus and related variant in human plasma. Emerg. Infect. Dis. 12(1), 151-154 (2006).
5. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E: New DNA viruses identifed in patients with acute viral infection syndrome. J. Virol. 79(13), 8230-8236 (2005).
6. Simmonds P, Douglas J, Bestetti G et al.: A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J. Gen. Virol. 89(Pt 9), 2299-2302 (2008).
7. Brown KE: The expanding range of parvoviruses which infect humans. Rev. Med. Virol. 20(4), 231-244 (2010).
8. Young NS, Brown KE: Parvovirus B19. N. Engl. J. Med. 350(6), 586-597 (2004)
9. Brown KE, Young NS, Liu JM: Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit. Rev. Oncol. Hematol. 16(1), 1-31 (1994).
10. de Jong EP, de Haan TR, Kroes AC, Beersma MF, Oepkes D, Walther FJ: Parvovirus B19 infection in pregnancy. J. Clin. Virol. 36(1), 1-7 (2006).
11. Al-Khan A, Caligiuri A, Apuzzio J: Parvovirus B-19 infection during pregnancy. Infect. Dis. Obstet. Gynecol. 11(3), 175-179 (2003).
12. Gloning KP, Schramm T, Brusis E, Schwarz T, Roggendorf M: Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection. Behring Ins. Mitt. (85), 79-85 (1990).
13. Schwarz TF, Nerlich A, Roggendorf M: Parvovirus B19 infection in pregnancy. Behring Inst. Mitt. (85), 69-73 (1990).
14. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B: Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl Acad. Sci. USA 102(36), 12891-12896 (2005).
15. Kapoor A, Slikas E, Simmonds P et al.: A newly identifed bocavirus species in human stool. J. Infect. Dis. 199(2), 196-200 (2009).
16. Arthur JL, Higgins GD, Davidson GP, Givney RC, Ratcliff RM: A novel bocavirus associated with acute gastroenteritis in Australian children. PLoS Pathog. 5(4), E1000391 (2009).
17. Kapoor A, Simmonds P, Slikas E et al.: Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J. Infect. Dis. 201(11), 1633-1643 (2010).
18. Martin ET, Fairchok MP, Kuypers J et al.: Frequent and prolonged shedding of bocavirus in young children attending daycare. J. Infect. Dis. 201(11), 1625-1632 (2010).
19. Best SM, Wolfnbarger JB, Bloom ME: Caspase activation is required for permissive replication of Aleutian mink disease parvovirus in vitro. Virology 292(2), 224-234 (2002).
20. Harrison LR, Styer EL, Pursell AR, Carmichael LE, Nietfeld JC: Fatal disease in nursing puppies associated with minute virus of canines. J. Vet. Diagn. Invest. 4(1), 19-22 (1992).
21. Carmichael LE, Schlafer DH, Hashimoto A: Pathogenicity of minute virus of canines (MVC) for the canine fetus. Cornell Vet. 81(2), 151-171 (1991).
22. Jarplid B, Johansson H, Carmichael LE: A fatal case of pup infection with minute virus of canines (MVC). J. Vet. Diagn. Invest. 8(4), 484-487 (1996).
23. Manteufel J, Truyen U: Animal bocaviruses: a brief review. Intervirology 51(5), 328-334 (2008).
24. Durham PJ, Lax A, Johnson RH: Pathological and virological studies of experimental parvoviral enteritis in calves. Res. Vet. Sci. 38(2), 209-219 (1985).
25. Parrish CR: Pathogenesis of feline panleukopenia virus and canine parvovirus. Baillieres Clin. Haematol. 8(1), 57-71 (1995).
26. Parrish CR, Leathers C W, Pearson R, Gorham JR: Comparisons of feline panleukopenia virus, canine parvovirus, raccoon parvovirus, and mink enteritis virus and their pathogenicity for mink and ferrets. Am. J. Vet. Res. 48(10), 1429-1435 (1987).
27. Parrish CR: Pathogenesis of feline panleukopenia virus and canine parvovirus. In: Parvoviruses. Kerr JR, Cotemore SF, Bloom ME, Linden RM, Parish CR (Eds). Hodder Arnold, London, UK (2006).
28. Van Leengoed LA, Vos J, Gruys E, Rondhuis P, Brand A: Porcine parvovirus infection: review and diagnosis in a sow herd with reproductive failure. Vet. Q. 5(3), 131-141 (1983).
29. Anderson MJ, Khousam MN, Maxwell DJ, Gould SJ, Happerfeld LC, Smith WJ: Human parvovirus B19 and hydrops fetalis. Lancet 1(8584), 535 (1988).
30. Brown KE, Young N: Pathogenesis of disease. In: Human Parvovirus B19. Anderson LJ, Young N (Eds). Karger, Basel, Switzerland 105-119 (1997).
31. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 281(5381), 1305-1308 (1998).
32. Chipuk JE, Bouchier-Hayes L, Green DR: Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ. 13(8), 1396-1402 (2006).
33. Ow YP, Green DR, Hao Z, Mak TW: Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell Biol. 9(7), 532-542 (2008).
34. Li P, Nijhawan D, Budihardjo I et al.: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4), 479-489 (1997).
35. Chen M, Wang J: Initiator caspases in apoptosis signaling pathways. Apoptosis 7(4), 313-319 (2002).
36. Roy S, Nicholson DW: Cross-talk in cell death signaling. J. Exp. Med. 192(8), F21-F25 (2000).
37. Basu A, Castle VP, Bouziane M, Bhalla K, Haldar S: Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res. 66(8), 4309-4318 (2006).
38. Degterev A, Yuan J: Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 9(5), 378-390 (2008).
39. Kroemer G, Galluzzi L, Vandenabeele P et al.: Classifcation of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16(1), 3-11 (2009).
40. Johnson DG, Walker CL: Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312 (1999).
41. Murray A: Cell cycle checkpoints. Curr. Opin. Cell Biol. 6(6), 872-876 (1994).
42. Branzei D, Foiani M: Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol. 9(4), 297-308 (2008).
43. Morey AL, Fleming KA: Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. Br. J. Haematol. 82(2), 302-309 (1992).
44. Ozawa K, Kurtzman G, Young N: Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233(4766), 883-886 (1986).
45. Srivastava A, Lu L: Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J. Virol. 62(8), 3059-3063 (1988).
46. Yaegashi N, Niinuma T, Chisaka H et al.: Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo. J. Infect. 39(1), 68-76 (1999).
47. Ozawa K, Kurtzman G, Young N: Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70(2), 384-391 (1987).
48. Morita E, Tada K, Chisaka H et al.: Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. J. Virol. 75(16), 7555-7563 (2001).
49. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K: Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J. Virol. 72(4), 3018-3028 (1998).
50. Shimomura S, Wong S, Brown KE, Komatsu N, Kajigaya S, Young NS: Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology 194(1), 149-156 (1993).
51. + erythroid progenitors are highly permissive to human parvovirus B19 replication. J. Virol. 82(5), 2470-2476 (2008).
52. Chen AY, Zhang EY, Guan W et al.: The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 115(5), 1070-1080 (2010).
53. Sol N, Le Junter J, Vassias I et al.: Possible interactions between the NS1 protein and tumor necrosis factor a pathways in erythroid cell apoptosis induced by human parvovirus B19. J. Virol. 73(10), 8762-8770 (1999).
54. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N: The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J. Virol. 62(8), 2884-2889 (1988).
55. Poole BD, Karetnyi YV, Naides SJ: Parvovirus B19-induced apoptosis of hepatocytes. J. Virol. 78(14), 7775-7783 (2004).
56. Hsu TC, Wu WJ, Chen MC, Tsay GJ: Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand. J. Infect. Dis. 36(8), 570-577 (2004).
57. Chisaka H, Morita E, Murata K et al.: A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19. J. Gen. Virol. 83(Pt 2), 273-281 (2002).
58. Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ: Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J. Virol. 80(8), 4114-4121 (2006).
59. Doerig C, Hirt B, Antonietti JP, Beard P: Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J. Virol. 64(1), 387-396 (1990).
60. Sol N, Morinet F, Alizon M, Hazan U: Trans-activation of the long terminal repeat of human immunodefciency virus type 1 by the parvovirus B19 NS1 gene product. J. Gen. Virol. 74 (Pt 9), 2011-2014 (1993).
61. Moffatt S, Tanaka N, Tada K et al.: A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol. 70(12), 8485-8491 (1996).
62. Gareus R, Gigler A, Hemauer A et al.: Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19. J. Virol. 72(1), 609-616 (1998).
63. Raab U, Beckenlehner K, Lowin T, Niller HH, Doyle S, Modrow S: NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3. Virology 293(1), 86-93 (2002).
64. Morita E, Sugamura K: Human parvovirus B19-induced cell cycle arrest and apoptosis. Springer Semin. Immunopathol. 24(2), 187-199 (2002).
65. Fan MM, Tamburic L, Shippam-Brett C, Zagrodney DB, Astell CR: The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner. Virology 291(2), 285-291 (2001).
66. Morita E, Nakashima A, Asao H, Sato H, Sugamura K: Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. J. Virol. 77(5), 2915-2921 (2003).
67. Guo YM, Ishii K, Hirokawa M et al.: CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells. Blood 115(22), 4569-4579 (2010).
68. Best SM, Shelton JF, Pompey JM, Wolfnbarger JB, Bloom ME: Caspase cleavage of the nonstructural protein NS1 mediates replication of Aleutian mink disease parvovirus. J. Virol. 77(9), 5305-5312 (2003).
69. Cheng F, Chen AY, Best SM, Bloom ME, Pintel D, Qiu J: The capsid proteins of Aleutian mink disease virus activate caspases and are specifcally cleaved during infection. J. Virol. 84(6), 2687-2696 (2010).
70. Oleksiewicz MB, Alexandersen S: S-phase-dependent cell cycle disturbances caused by Aleutian mink disease parvovirus. J. Virol. 71(2), 1386-1396 (1997).
71. Dijkman R, Koekkoek SM, Molenkamp R, Schildgen O, van der Hoek L: Human bocavirus can be cultured in differentiated human airway epithelial cells. J. Virol. 83(15), 7739-7748 (2009).
72. Chen AY, Cheng F, Lou S et al.: Characterization of the gene expression profle of human bocavirus. Virology 403 (2), 145-154 (2010).
73. Qiu J, Cheng F, Johnson FB, Pintel D: The transcription profle of the bocavirus bovine parvovirus is unlike those of previously characterized parvoviruses. J. Virol. 81(21), 12080-12085 (2007).
74. Chen AY, Luo Y, Cheng F, Sun Y, Qiu J: Bocavirus infection induces mitochondrion-mediated apoptosis and cell cycle arrest at G2/M phase. J. Virol. 84(11), 5615-5626 (2010).
75. Binn LN, Marchwicki RH, Eckermann EH, Fritz TE: Viral antibody studies of laboratory dogs with diarrheal disease. Am. J. Vet. Res. 42(10), 1665-1667 (1981).
76. Sun Y, Chen AY, Cheng F, Guan W, Johnson FB, Qiu J: Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J. Virol. 83(8), 3956-3967 (2009).
77. Abdel-Latif L, Murray BK, Renberg RL et al.: Cell death in bovine parvovirus-infected embryonic bovine tracheal cells is mediated by necrosis rather than apoptosis. J. Gen. Virol. 87(Pt 9), 2539-2548 (2006).
78. Srivastava A: Hematopoietic stem cell transduction by recombinant adeno-associated virus vectors: problems and solutions. Hum. Gene Ther. 16(7), 792-798 (2005).
79. Srivastava A: Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors. J. Cell Biochem. Suppl. 38, 39-45 (2002).
80. Rohde V, Erles K, Sattler HP, Derouet H, Wullich B, Schlehofer JR: Detection of adeno-associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertil. Steril. 72(5), 814-816 (1999).
81. Burguete T, Rabreau M, Fontanges-Darriet M et al.: Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum. Reprod. 14(9), 2396-2401 (1999).
82. Arechavaleta-Velasco F, Ma Y, Zhang J, McGrath CM, Parry S: Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. Am. J. Pathol. 168(6), 1951-1959 (2006).
83. Arechavaleta-Velasco F, Gomez L, Ma Y et al.: Adverse reproductive outcomes in urban women with adeno-associated virus-2 infections in early pregnancy. Hum Reprod. 23(1), 29-36 (2008).
84. Duverger V, Sartorius U, Klein-Bauernschmitt P, Krammer PH, Schlehofer JR: Enhancement of cisplatin-induced apoptosis by infection with adeno-associated virus type 2. Int. J. Cancer. 97(5), 706-712 (2002).
85. Timpe JM, Verrill KC, Black BN, Ding HF, Trempe JP: Adeno-associated virus induces apoptosis during coinfection with adenovirus. Virology 358(2), 391-401 (2007).
86. Raj K, Ogston P, Beard P: Virus-mediated killing of cells that lack p53 activity. Nature 412(6850), 914-917 (2001).
87. Garner E, Martinon F, Tschopp J, Beard P, Raj K: Cells with defective p53-p21-pRb pathway are susceptible to apoptosis induced by p84N5 via caspase-6. Cancer Res. 67(16), 7631-7637 (2007).
88. Jurvansuu J, Fragkos M, Ingemarsdotter C, Beard P: Chk1 instability is coupled to mitotic cell death of p53-defcient cells in response to virus-induced DNA damage signaling. J. Mol. Biol. 372(2), 397-406 (2007).
89. Schmidt M, Afone S, Kotin RM: Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J. Virol. 74(20), 9441-9450 (2000).
90. Saudan P, Vlach J, Beard P: Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J. 19(16), 4351-4361 (2000).
91. Jurvansuu J, Raj K, Stasiak A, Beard P: Viral transport of DNA damage that mimics a stalled replication fork. J. Virol. 79(1), 569-580 (2005).
92. Fragkos M, Breuleux M, Clement N, Beard P: Recombinant adeno-associated viral vectors are defcient in provoking a DNA damage response. J. Virol. 82(15), 7379-7387 (2008).
93. Ingemarsdotter C, Keller D, Beard P: The DNA damage response to non-replicating adeno-associated virus: centriole overduplication and mitotic catastrophe independent of the spindle checkpoint. Virology 400(2), 271-286 (2010).
94. Fragkos M, Jurvansuu J, Beard P: H2AX is required for cell cycle arrest via the p53/p21 pathway. Mol. Cell Biol. 29(10), 2828-2840 (2009).
95. Schwartz RA, Carson CT, Schuberth C, Weitzman MD: Adeno-associated virus replication induces a DNA damage response coordinated by DNA-dependent protein kinase. J. Virol. 83(12), 6269-6278 (2009).
96. Collaco RF, Bevington JM, Bhrigu V, Kalman-Maltese V, Trempe JP: Adeno-associated virus and adenovirus coinfection induces a cellular DNA damage and repair response via redundant phosphatidylinositol 3-like kinase pathways. Virology 392(1), 24-33 (2009).
97. Bauder B, Suchy A, Gabler C, Weissenbock H: Apoptosis in feline panleukopenia and canine parvovirus enteritis. J. Vet. Med. B. Infect. Dis. Vet. Public Health 47(10), 775-784 (2000).
98. Ohshima T, Iwama M, Ueno Y et al.: Induction of apoptosis in vitro and in vivo by H-1 parvovirus infection. J. Gen. Virol. 79(Pt 12), 3067-3071 (1998).
99. Rayet B, Lopez-Guerrero JA, Rommelaere J, Dinsart C: Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway. J. Virol. 72(11), 8893-8903 (1998).
100. Roperch JP, Lethrone F, Prieur S et al.: SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and traffcking: identifcation of common effectors with p53 and p21(Waf1). Proc. Natl Acad. Sci. USA 96(14), 8070-8073 (1999).
101. Di Piazza M, Mader C, Geletneky K et al.: Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells. J. Virol. 81(8), 4186-4198 (2007).
102. Nuesch JP, Rommelaere J: NS1 interaction with CKII a: novel protein complex mediating parvovirus-induced cytotoxicity. J. Virol. 80(10), 4729-4739 (2006).
103. Mousset S, Rommelaere J: Minute virus of mice inhibits cell transformation by simian virus 40. Nature 300(5892), 537-539 (1982).
104. Chen YQ, de Foresta F, Hertoghs J, Avalosse BL, Cornelis JJ, Rommelaere J: Selective killing of simian virus 40-transformed human fbroblasts by parvovirus H-1. Cancer Res. 46(7), 3574-3579 (1986).
105. Cornelis JJ, Spruyt N, Spegelaere P et al.: Sensitization of transformed rat fbroblasts to killing by parvovirus minute virus of mice correlates with an increase in viral gene expression. J. Virol. 62(9), 3438-3444 (1988).
106. Cornelis JJ, Becquart P, Duponchel N et al.: Transformation of human fbroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. J. Virol. 62(5), 1679-1686 (1988).
107. Nuesch JP, Corbau R, Tattersall P, Rommelaere J: Biochemical activities of minute virus of mice nonstructural protein NS1 are modulated in vitro by the phosphorylation state of the polypeptide. J. Virol. 72(10), 8002-8012 (1998). (Pubitemid 28421793)
108. Nuesch JP, Dettwiler S, Corbau R, Rommelaere J: Replicative functions of minute virus of mice NS1 protein are regulated in vitro by phosphorylation through protein kinase C. J. Virol. 72(12), 9966-9977 (1998). (Pubitemid 28520864)
109. Mousset S, Ouadrhiri Y, Caillet-Fauquet P, Rommelaere J: The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. J. Virol. 68(10), 6446-6453 (1994).
110. Daeffer L, Horlein R, Rommelaere J, Nuesch JP: Modulation of minute virus of mice cytotoxic activities through site-directed mutagenesis within the NS coding region. J. Virol. 77(23), 12466-12478 (2003).
111. Nuesch JP, Lachmann S, Rommelaere J: Selective alterations of the host cell architecture upon infection with parvovirus minute virus of mice. Virology 331(1), 159-174 (2005).
112. Corbau R, Duverger V, Rommelaere J, Nuesch JP: Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 278(1), 151-167 (2000).
113. Nuesch JP, Rommelaere J: A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proc. Natl Acad. Sci. USA 104(30), 12482-12487 (2007).
114. Riolobos L, Valle N, Hernando E, Maroto B, Kann M, Almendral JM: Viral oncolysis that targets Raf-1 signaling control of nuclear transport. J. Virol. 84(4), 2090-2099 (2010).
115. Foghsgaard L, Wissing D, Mauch D et al.: Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153(5), 999-1010 (2001).
116. Guicciardi ME, Deussing J, Miyoshi H et al.: Cathepsin B contributes to TNF-a-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106(9), 1127-1137 (2000).
117. Hristov G, Kramer M, Li J et al.: Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J. Virol. 84(12), 5909-5922 (2010).
118. Liu J, Ran ZH, Xiao SD, Rommelaere J: Changes in gene expression profles induced by parvovirus H-1 in human gastric cancer cells. Chin. J. Dig. Dis. 6(2), 72-81 (2005).
119. Op De Beeck A, Anouja F, Mousset S, Rommelaere J, Caillet-Fauquet P: The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2. Cell Growth Differ. 6(7), 781-787 (1995).
120. Anouja F, Wattiez R, Mousset S, Caillet-Fauquet P: The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins. J. Virol. 71(6), 4671-4678 (1997).
121. Op De Beeck A, Caillet-Fauquet P: The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin? J. Virol. 71(7), 5323-5329 (1997).
122. Op De Beeck A, Sobczak-Thepot J, Sirma H, Bourgain F, Brechot C, Caillet-Fauquet P: NS1-and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1). J. Virol. 75(22), 11071-11078 (2001).
123. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G: Viral control of mitochondrial apoptosis. PLoS Pathog. 4(5), e1000018 (2008).
124. Nguyen ML, Blaho JA: Apoptosis during herpes simplex virus infection. Adv. Virus Res. 69, 67-97 (2007).
125. Best SM: Viral subversion of apoptotic enzymes: escape from death row. Annu. Rev. Microbiol. 62, 171-192 (2008).
126. Haanen C, Vermes I: Apoptosis and infammation. Mediators Infammation 4(1), 5-15 (1995).
127. Pombo A, Ferreira J, Bridge E, Carmo-Fonseca M: Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J. 13(21), 5075-5085 (1994). (Pubitemid 24341089)
128. Moehler M, Blechacz B, Weiskopf N et al.: Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther. 8(3), 158-167 (2001).
129. Ran Z, Rayet B, Rommelaere J, Faisst S: Parvovirus H-1-induced cell death: infuence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Res. 65(2), 161-174 (1999).
130. Davy C, Doorbar J: G2/M cell cycle arrest in the life cycle of viruses. Virology 368 (2), 219-226 (2007).
131. Zhao RY, Elder RT: Viral infections and cell cycle G2/M regulation. Cell Res. 15(3), 143-149 (2005).
132. Wolter S, Richards R, Armentrout RW: Cell cycle-dependent replication of the DNA of minute virus of mice, a parvovirus. Biochem. Biophys. Acta 607(3), 420-431 (1980).
133. Robertson AT, Stout ER, Bates RC: Aphidicolin inhibition of the production of replicative-form DNA during bovine parvovirus infection. J. Virol. 49(3), 652-657 (1984).
134. Durham PJ, Johnson RH: Studies on the replication of a bovine parvovirus. Vet. Microbiol. 10(2), 165-177 (1985).
135. Metcalf JB, Bates RC, Lederman M: Interaction of virally coded protein and a cell cycle-regulated cellular protein with the bovine parvovirus left terminus Ori. J. Virol. 64(11), 5485-5490 (1990).
136. Tennant RW, Layman KR, Hand RE: Effect of cell physiological state on infection by rat virus. J. Virol. 4(6), 872-878 (1969).
137. Guetta E, Ron D, Tal J: Development-dependent replication of minute virus of mice in differentiated mouse testicular cell lines. J. Gen. Virol. 67(Pt 11), 2549-2554 (1986).
138. Bonvicini F, Filippone C, Manaresi E, Zerbini M, Musiani M, Gallinella G: Functional analysis and quantitative determination of the expression profle of human parvovirus B19. Virology 381(2), 168-177 (2008).
139. Trobridge G, Hirata RK, Russell DW: Gene targeting by adeno-associated virus vectors is cell-cycle dependent. Hum. Gene Ther. 16(4), 522-526 (2005).
140. Hermanns J, Schulze A, Jansen-Db1urr P, Kleinschmidt JA, Schmidt R, zur Hausen H: Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J. Virol. 71(8), 6020-6027 (1997).
141. Winocour E, Callaham MF, Huberman E: Perturbation of the cell cycle by adeno-associated virus. Virology 167(2), 393-399 (1988).
142. Berthet C, Raj K, Saudan P, Beard P: How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc. Natl Acad. Sci. USA 102(38), 13634-13639 (2005).
143. Meikrantz W, Schlegel R: Apoptosis and the cell cycle. J. Cell Biochem. 58(2), 160-174 (1995).
144. Vermeulen K, Berneman ZN, Van Bockstaele DR: Cell cycle and apoptosis. Cell Prolif. 36(3), 165-175 (2003).
145. Zinkel S, Gross A, Yang E: BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 13(8), 1351-1359 (2006).
146. Clarke PR, Allan LA: Cell-cycle control in the face of damage-a matter of life or death. Trends Cell Biol. 19(3), 89-98 (2009).
147. Cotmore SF, Tattersall P: A rolling-hairpin strategy: basic mechanisms of DNA replication in the parvoviruses. In: Parvoviruses. Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR (Eds). Hodder Arnold, London, UK (2006).
148. Nash K, Chen W, Muzyczka N: Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins. J. Virol. 82(3), 1458-1464 (2008).